Almay Clear Complexion Makeup Foundation

Description

The product, identified by SPL Code 34089-3, is a cosmetic formulation intended for use as a makeup product. It comprises a blend of active and inactive ingredients that collectively enhance its properties and effectiveness. This formulation is specifically designed to provide coverage while improving the overall appearance of the skin. Additionally, the product is packaged to ensure stability and usability, facilitating optimal consumer experience.

Uses and Indications

This drug is indicated for the treatment of acne vulgaris. It helps clear existing acne blemishes and prevent the formation of new acne lesions.

Dosage and Administration

Clean the skin thoroughly before application of the product. The product should be applied evenly from the center of the face outward, covering the entire affected area with a thin layer. Initial dosing should begin with one application daily. Based on the patient's response and as directed by a healthcare professional, the frequency may be gradually increased to two to three times daily.

In cases where bothersome dryness or peeling occurs, it is recommended to reduce the application frequency to once a day or every other day. For new users, a sensitivity test is advised: apply the product sparingly to one or two small affected areas during the first three days. If no discomfort is experienced, the user may then proceed to follow the standard application instructions.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to exercise caution when using this product, particularly in conjunction with other topical acne medications. The concurrent use of multiple topical agents may increase the likelihood of skin irritation and dryness. In the event that irritation occurs, it is recommended that patients limit their use to one topical acne medication at a time to mitigate adverse effects.

Additionally, it is imperative to avoid contact with the eyes. Should accidental contact occur, patients should be instructed to flush the affected area thoroughly with water to prevent potential complications. Regular monitoring of the skin's response to treatment is advised to ensure patient safety and to address any adverse reactions promptly.

Side Effects

Patients using this medication may experience skin irritation and dryness, particularly if they concurrently use another topical acne medication. It is advised that only one topical acne medication be used at a time to minimize the risk of irritation.

Additionally, patients should avoid contact with the eyes. In the event of accidental contact, it is recommended to flush the eyes thoroughly with water to alleviate any potential discomfort.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications is recommended to alleviate symptoms. Monitoring for signs of skin irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Almay Clear Complexion Makeup Foundation (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this product out of reach of children. In the event that the product is swallowed, it is crucial to seek medical assistance or contact a poison control center immediately.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Safety during pregnancy has not been established for this product. The use of this product is contraindicated in pregnancy due to potential risks to the fetus. Salicylic acid, particularly at high doses, may pose a risk to the developing fetus. Therefore, pregnant women are advised to consult a healthcare provider before using this product to discuss potential risks and alternative options.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no information available regarding renal impairment, including dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of specific guidance when treating patients with renal impairment.

Hepatic Impairment

There is no available information regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise caution and consider the overall clinical context when prescribing this medication to patients with liver problems, as the absence of specific guidance necessitates careful evaluation of potential risks and benefits.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, ensuring adequate ventilation, and monitoring vital signs.

If available, the use of activated charcoal may be considered to limit further absorption of the substance, provided that the patient is alert and able to protect their airway.

In cases where specific antidotes are known, they should be administered as per established protocols. Continuous assessment and supportive measures are critical in managing the patient's condition until they stabilize.

Healthcare professionals are encouraged to report any cases of overdose to the appropriate regulatory authorities and consult poison control centers for additional guidance tailored to the specific circumstances of the overdose.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of the reach of children to prevent accidental ingestion or misuse. It is important for patients to understand the potential risks associated with improper access to the medication by young children.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain integrity. It should be stored at a temperature range of 20°C to 25°C (68°F to 77°F) and protected from light to prevent degradation. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically and is intended for external use only. Clinicians should advise patients that the likelihood of skin irritation and dryness increases when using this product concurrently with other topical acne medications. If irritation occurs, patients should limit their use to one topical acne medication at a time.

Patients are also cautioned to avoid contact with the eyes; in the event of contact, they should flush the eyes thoroughly with water. Additionally, the product should be kept out of reach of children, and if ingested, medical assistance or contact with a poison control center should be sought immediately.

Drug Information (PDF)

This file contains official product information for Almay Clear Complexion Makeup Foundation, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)